Research - October 2023 Archives

Risk can be a complicated and confounding concept, particularly when it comes to life-or-death situations like cancer. The discovery of the BRCA1 and BRCA2 genes ...

One of the challenges in addressing Alzheimer's disease, dementia, cognitive impairment and aging is not related to the conditions themselves but rather the terminology. That’s ...

Most lumps or nodules in the thyroid, which is a gland in your neck, are not harmful and don't need treatment. But sometimes, they can grow bigger ...

ROCHESTER, Minn. — Artificial intelligence (AI) from patient electrocardiograms (ECGs) may be an innovative solution to enhance heart disease risk assessment. Atherosclerotic cardiovascular disease — ...

A recent Mayo Clinic study of residents living in a mostly rural, 11‐county region of southeast Minnesota found that patients with heart failure and multiple social risk ...

Mayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatment for triple-negative breast ...

Mayo Clinic Research leaders are excited to announce the arrival of Owen Garrick, M.D., as the dean of Clinical Trials. Dr. Garrick will start in ...

Forty-eight international experts on membranous nephropathy have co-authored a consensus report that calls for a new method of classifying diagnoses of the syndrome. They say ...

Mayo Clinic researchers have developed a new high-resolution, analytical technique to identify the rare senescent bone cells that are known to drive osteoporosis. Senescent cells are ...

Ultrasound — a technology that uses sound waves to produce an image — is commonly used to monitor the development of a baby as it grows ...

In a recent study, Mayo Clinic researchers examined telomere biology disorders, a group of rare genetic disorders characterized by short telomeres. Telomeres are long segments at ...

Mayo Clinic research has developed a new type of chimeric antigen receptor-T cell therapy (CAR-T cell therapy) aimed at killing B-cell blood cancers that have ...